Early reperfusion is mandatory for the treatment of acute myocardial infarction. This process, however, also induces additional loss of viable myocardium, called ischaemia-reperfusion (IR) injury. Complement activation plays an important role in IR injury, partly through binding of C5a to its major receptor (C5aR). We investigated the role of C5aR on infarct size and cardiac function in a model for myocardial IR injury.
Introduction
Early restoration of antegrade coronary blood flow is the best available treatment for acute myocardial infarction (AMI). Despite tremendous improvements in this field, patients still experience severe myocardial injury and subsequent heart failure due to ischaemia-reperfusion (IR) injury, for which to date no clinically approved therapy exists. 1 A large part of the IR injury consists of myocardial damage induced by activation of the immune system and attraction of inflammatory cells into the infarcted area upon reperfusion. 2 -4 The complement system, as a part of the innate immune system, has been investigated for decades as a possible therapeutic target to limit IR injury in several organs. 5 -7 Already in the 1970s, inhibition of components of the complement system was shown to reduce myocardial injury in animal models. 8, 9 The complement system classically becomes activated by pathogens, but can also get activated by danger associated molecular patterns (DAMPs) and endogenous ligands released upon ischaemia and reperfusion. 10 -14 A complex activation cascade involving several regulating components leads to the production of, among others, anaphylatoxins C3a, C4a, and C5a of which the latter one is the most potent inflammatory activator. Upon binding to its receptor (C5aR), C5a induces an inflammatory response by chemotaxis of inflammatory cells, vasodilation, and up-regulation of endothelial adhesion molecules. Recently, blocking of C5 with an anti-C5 antibody has been investigated in clinical trials in the setting of primary percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). 15 -18 Unfortunately, this treatment did not prove to be effective in improving the patient outcome. 19 Since blocking components early in the complement pathway affects several effector functions of the complement system, 20 we hypothesized that the receptor for C5a (C5aR; CD88), as one of the main downstream receptors involved in influx of inflammatory cells, would be a potential target to reduce myocardial IR injury. The C5aR is a G-protein coupled receptor expressed on several inflammatory cells, e.g. neutrophils, dendritic cells, mast cells, monocytes, and T cells, but also on endothelial cells and other parenchymal cells such as cardiomyocytes. 21 -23 Neutrophils as well as T cells are known to be crucial players in the process of IR injury in several organs. 24 -29 Neutrophils invade the myocardium in the first hours after reperfusion, enabling them to cause major injury during early reperfusion. 26, 30, 31 In support of a role for neutrophils and C5aR in myocardial IR, it was recently shown that C5aR knockout (C5aR 2/2 ) mice have reduced infarct sizes after myocardial IR injury, which correlated with a reduction of neutrophils infiltrating the infarct area. 32 25, 33, 34 C5aR can be expressed by T-cell populations and has been shown to be involved in differentiation and chemotaxis of these cells, in mice and in humans. 35 -38 However, a distinct role for C5aR on T-cell responses has not been investigated in a myocardial IR injury setting to date. Finally, the long-term effects of C5aR-deficiency on cardiac function and adverse remodelling after myocardial IR have not been investigated. In this study, we therefore aimed to elucidate the role of C5aR expression on BM-derived cells as well as on parenchymal cells in mediating myocardial IR injury, and ultimate cardiac function and remodelling. We utilized BM chimaera mice to differentiate the role of peripheral BM leucocyte C5aR and parenchymal C5aR after myocardial IR injury. We show that the absence of leucocyte C5aR is solely responsible for beneficial outcomes in C5aR 2/2 mice after IR, and is associated with a marked reduction of neutrophil, T cell, and macrophage infiltration into the infarcted myocardium. We also find a reduction in C3 deposition in C5aR 2/2 mice, suggesting that leucocyte-mediated myocardial injury via C5aR is associated with amplifying complement-mediated damage. 
Methods

Animals
Infarct size determination
At 24 h after myocardial IR, the LCA was re-ligated and the hearts were perfused with 2% Evans Blue dye (Sigma-Aldrich) by retrograde injection into the descending aorta, to indicate area at risk (AAR). After dissection of the heart, the left ventricle was isolated and cut in 1 mm slices, followed by staining with 2% 
Bone marrow transplantations
Femura and tibiae from WT mice and C5aR 2/2 mice were explanted after euthanasia (by cervical dislocation), and cleaned from soft tissue. Bone marrow (BM) cells were isolated by flushing the bones with RPMI-1640 medium with a 30G needle, in a sterile environment. The suspension was centrifuged for 10 min at 250 g and the pellet was re-suspended with RPMI-1640 to a concentration of 20 × 10 6 cells/mL.
Recipient mice were irradiated with lethal doses of consecutively 700 and 200 cGy (1030 monitorunits, 10 MeV) to destroy the BM. Afterwards, mice received 5 × 10 6 donor BM cells in 250 mL RPMI-1640 medium via tail vein injection and were allowed to recover for 6 weeks to ensure engraftment of the donor BM. Successful chimaerization (.95% circulating donor cells) was confirmed after 6 weeks by measuring the percentage of C5aR expressing leucocytes and specifically neutrophils in venous blood samples by flow cytometry (Cytomics FC500, Beckman Coulter) using an anti-Ly6G antibody (rat anti-mouse Ly6G, clone RB6-8C5, eBioscience) and an anti-C5aR antibody (rat anti-mouse C5aR, clone 20/70, AbD Serotec) (see Supplementary material online, Figure S1 ). Four groups of chimaeric mice were created: WT BM transplanted in WT mice, C5aR 2/2 BM transplanted in C5aR 2/2 mice, WT BM transplanted in C5aR 2/2 mice, and C5aR 2/2 BM transplanted in WT mice. After 6 weeks engraftment, these mice were subjected to myocardial IR injury, as described earlier.
Cardiac function assessment
All measurements of cardiac function were performed with a Vevo w 2100 ultrasound system (Visualsonics Inc.) and analysed with Vevo w 2100 software, version 1.3.0. Echocardiography was performed at baseline and 4 weeks after myocardial IR, under general anaesthesia (Isoflurane 4% during induction, continuous 1.5-2.5% during measurements, in 100% oxygen). Temperature was monitored with a rectal probe and core body V.C. De Hoog et al.
temperature was maintained constant at 36-378C. Volumes and functional parameters were measured in parasternal long-axis view (LV trace mode). The measurements were performed in duplo, after which mean values were used for further statistical analysis.
Immunohistochemistry
Immunohistochemical stainings were performed on paraffin-embedded isolated left ventricles. Fixed tissue was cut into 5 mm sections. Tissue sections were stained for neutrophils with an anti-Ly6G antibody (rat anti-mouse Ly6G, clone RB6-8C5, Abcam), for T cells with an anti-CD3 antibody (rabbit anti-human CD3, clone F7.2.38, Dako), for macrophages with an anti-MAC3 antibody (rat anti-mouse MAC3, clone M3/84, BD Biosciences), and for C3 with an anti-C3 antibody (rabbit anti-mouse C3, clone E28-P, Abnova), according to the manufacturer's protocols. All sections were counterstained with haematoxylin to visualize the cell nuclei. Stained sections were examined by digital light microscopy. Digital images were analysed with CellP software (Olympus Europe, Version 2.8) in a blinded fashion. Neutrophils, T cells, and macrophages were counted in the whole infarct area by automatic detection and numbers were corrected for infarct area (cells/mm 2 ). C3 deposition was measured as percentage positive staining of total infarct area (% of area). The infarct area was assessed visually as the area delineated by the borderzone between disrupted and intact myocardium.
Collagen density 4 weeks after IR was determined with Picrosirius Red staining. Stained sections were examined by digital light microscopy to determine infarct area and polarized light microscopy to determine collagen area and intensity. Collagen density was expressed as grey value per mm 2 infarct area.
Protein isolation from infarcted myocardial tissue
Infarcted myocardial tissue was dissolved in 250 mL tissue lysis buffer (cOmplete Lysis-M, Roche). Lysis buffer was added to the tissue samples as well as zirconium oxide beads (Bertin Technologies), after which they were processed for 2 × 30 s using a tissue homogenizer (Precellys 24, Bertin Technologies) and kept on ice for 30 min. After spinning the samples 2 × 10 min at 25 000 g the supernatant was stored at 2808C. Sample protein concentration was measured with a BCA protein assay (Thermo Scientific). All measurements were corrected for protein concentration.
Cytokine and chemokine measurements
Concentrations of TNFa, IL6 (ProcartaPlex assays, eBioscience), KC (the mouse analogue of IL8), MIP-1a, and G-CSF (Bio-Plex Pro assays, Bio-Rad) were measured in plasma and infarcted tissue with multiplex Luminex assays on a Bio-Plex 200 multiplex suspension array system (Bio-Rad), according to the manufacturer's protocol. Plasma samples were diluted 1:1 and concentrations were expressed as pg/mL. For infarct measurements, 30 mg of protein per sample was loaded and measured concentrations were expressed as ng/mg protein.
Caspase-3/7 measurements in infarcted tissue
Caspase-3/7 concentration in the infarcted tissue was measured with a luminescent assay (Caspase-Glo 3/7 assay, Promega), according to the manufacturer's protocol. Per sample 25 mg of protein was loaded and concentrations were expressed as relative light units (RLU).
Flow cytometry
Whole blood was collected in EDTA blood collection tubes at baseline and at 1 and 24 h after IR, after which 50 mL whole blood was incubated with a mix containing antibodies against Ly6G (rat anti-mouse Ly6G-APC, clone 1A8, BD Biosciences), Ly6C (rat anti-mouse Ly6C-eFluor450, clone HK1.4, eBioscience), CD3 (hamster anti-mouse CD3e-FITC, clone eBio500A2, eBioscience), CD4 (rat anti-mouse CD4-eFluor450, clone RM4-5, eBioscience), CD8 (rat anti-mouse CD8a-APC-eFluor780, clone 53 -6.7, eBioscience), CD11b (rat anti-mouse CD11b-APCeFluor780, clone M1/70, eBioscience), and CD62L (rat anti-mouse CD62L-APC, clone MEL-14, eBioscience). The samples were analysed on a Gallios flow cytometer (Beckman Coulter). White blood cell concentration was measured on a Cell-Dyn 3200 automatic cell counter (Abbott Diagnostics 
Statistical analysis
Comparisons between two groups were performed with Mann-Whitney U tests. Multiple group comparisons were performed with one-way ANOVA with LSD post hoc analysis (see Supplementary material online, Figure S2 ). 35.7 + 2.5% (WT), P ¼ 0.017) at 24 h after myocardial IR (Figure 1 ). There were no differences in AAR between the groups (see Supplementary material online, Figure S2 ). There were also no differences in mortality after myocardial IR: one WT mouse and two C5aR 2/2 mice died ,24 h after IR. Figure 2A ). The improved ejection fraction was mainly attributable to an improvement in end-systolic volume (ESV) ( Table 1 ). In line with this, cardiac output was also markedly higher in C5aR 2/2 mice (13.9 + 0.7 mL/min (C5aR 2/2 ) vs. 11.3 + 0.57 mL/min (WT), P , 0.05) ( Table 1) . There was no difference in heart rate between the groups. Also there were no differences in mortality during follow-up. Both groups consisted of 20 mice at baseline. One WT mouse and two C5aR 2/2 mice died ,24 h after IR. Five C5aR 2/2 mice and one WT mouse were euthanized during follow-up because of severe injuries due to fighting. Picrosirius Red staining for collagen showed that collagen density in the infarct area 4 weeks after IR was higher in C5aR 
Absence of C5aR on bone marrow-derived cells determines infarct size reduction
To investigate the relative role of C5aR on parenchymal cells and on BM-derived cells in myocardial IR injury, BM transplantations were performed to create chimaeric mice. Leucocyte expression of C5aR in mice transplanted with BM cells lacking C5aR was ,1% (see Supplementary material online, Figure S1 ), indicating successful chimaerization. There was no difference in mortality between the groups: two mice died ,24 h in the group of C5aR 2/2 mice transplanted with WT BM and also two died in the group of WT mice transplanted with C5aR 2/2 BM. Figure 3 ).
This implicates that C5aR on BM-derived cells, rather than on parenchymal cells, determines infarct size. EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction; CO, cardiac output; SV, stroke volume; HR, heart rate; Sign, significance (P-value).
Influx of inflammatory cells and complement activation in the infarct area after myocardial IR
In order to investigate differences in inflammatory cells infiltrating the infarct area following myocardial IR, neutrophils, T cells, and macrophages in the infarct area were quantified after myocardial IR. Infarct analysis showed large infiltration of neutrophils between 1 and 24 h after myocardial IR, but markedly less in C5aR 
Less apoptosis in the infarcted tissue of C5aR 2/2 mice after myocardial IR
Caspase-3/7 concentration in the infarcted tissue, as a marker of apoptosis, was lower at 24 h after myocardial IR (15 100 + 961 RLU (C5aR) vs. 18 947 + 1090 RLU (WT), P , 0.01) ( Figure 5) . Although plasma levels of pro-inflammatory cytokine TNFa were lower in C5aR Figure S4 ). The concentration of the chemokines KC (the mouse analogue of IL8) and MIP-1a and of G-CSF, which direct leucocyte migration into the tissue and the production of granulocytes in the bone marrow, respectively, did not differ between the groups within 24 h after myocardial IR, in plasma nor in the infarcted tissue (see Supplementary material online, Table S1 ).
Less circulating T cells following myocardial IR
One hour after IR, there was a marked increase of circulating leucocytes (neutrophils, monocytes, and T cells) in WT mice, but much less in C5aR 2/2 mice (7.2 + 0.5 × 10 6 cells/mL (C5aR 2/2 ) vs. 10.8 + 0.9 × ( Figure 6D) , with strongest effects on CD4+ T cells, also persisting after 24 h ( Figures 6E and F) . This trend was also visible in circulating monocytes, although not significant ( Figure 6C ). There were no differences in circulating neutrophils following IR between the groups ( Figure 6B ).
Discussion
In this study, we show that absence of C5aR selectively on BM-derived cells leads to a reduced infarct size after myocardial IR injury. This effect is likely mediated by an early reduction of neutrophil, T cell, and macrophage influx in the infarct area, and translated into improved cardiac function after myocardial IR injury. It was recently shown that mice lacking C5aR have a reduced infarct size 24 h after myocardial IR. 32 In our study, we confirm these findings and show that this early infarct size reduction in mice lacking C5aR results in improved cardiac function after 4 weeks (Figure 2A ), without increased mortality; an important finding in view of possible future clinical application of C5aR inhibitors. Analysis of the scar composition showed more collagen in C5aR 2/2 mice 4 weeks after IR ( Figure 2B ). The higher collagen density probably leads to a firmer scar that provides resistance to the intraventricular pressure and thereby contributes to prevention of outward remodelling and deterioration of systolic cardiac function. An early infarct size reduction has also been reported after treatment with an anti-C5aR antibody just prior to reperfusion in mice 32 as well as in pigs, 39 indicating that C5aR exerts its pathogenic effect during reperfusion, not (only) during ischaemia. Our BM transplantation studies showed that the infarct size reduction was only present in mice lacking C5aR on BM-derived cells, not parenchymal cells. This implicates that C5aR on parenchymal cells, e.g. endothelial cells, cardiomyocytes, or resident inflammatory cells, does not play a role in the determination of infarct size in the setting of myocardial IR injury in mice. Interestingly, this is in line with previous findings, showing that lack of TLR2 expression on circulating leucocytes also leads to infarct size reduction after myocardial IR. 40 Similar results
were also seen in a study showing that targeted deletion of NFkBp50 C5a receptors in myocardial reperfusion injury on circulating leucocytes results in enhanced cardiac remodelling and deterioration of cardiac function in a myocardial infarction model. 41 Also in patients with ST elevation MI, the extent of TLR (2 and 4) activation correlates with infarct size as measured with cardiac magnetic resonance imaging. 42 These observations suggest that receptor signalling on the leucocytes themselves drives the invasion of inflammatory Blockade or the absence of C5aR in mice has been shown to result in reduced neutrophil influx into the infarct area following myocardial IR injury. 32, 43 We now extend these findings and demonstrate that reduced influx of inflammatory cells is not limited to neutrophils. Our studies show that the influx of T cells and macrophages is also strikingly reduced in the infarct area of C5aR 2/2 mice. T cells were seen to invade the myocardium even earlier than neutrophils, within 1 h after reperfusion ( Figure 4B ). This is in accordance with previous studies showing rapid influx of T cells, even in the first minutes after the induction of reperfusion. 34, 40 Although much research is devoted to the role of neutrophils in the setting of IR injury, in the last decade there have been emerging reports on the importance of T cells in this process. T cells have been shown to be important invaders following reperfusion in several organs. 25, 34, 44 CD4+ T-cell depletion results in infarct size reduction in a mouse myocardial IR model, implicating their importance in this process. 34 Neutrophil infiltration is also reduced in mice lacking CD4+ T cells and is restored by adoptive transfer of CD4+ T cells, implicating that T cells drive neutrophil chemotaxis following IR. 34 The
C5aR is present on many inflammatory cells, with several studies also demonstrating T-cell expression of C5aR. Stimulation of T-cell C5aR was shown to induce differentiation, proliferation, and chemotaxis of T cells. 35 -38 In this study, we show in a myocardial IR model that lack of C5aR leads to an almost complete abrogation of T cells invading the myocardium ( Figure 4B ). In contrast, neutrophil influx is reduced, but not completely blocked at 24 h after myocardial IR, compared with baseline levels ( Figure 4A ). This identifies the C5aR as an essential component in the regulation of T-cell migration into the heart, and possibly subsequent neutrophil infiltration. How lack of leucocytic C5aR reduces leucocyte influx into the infarct area has not been fully elucidated. Apart from reduced plasma TNFa levels, we observed no differences in cytokine-and chemokine levels in the infarct area or plasma (see Supplementary material online, Figure S4 and Supplementary material online, Table S1 ). Also endothelial adhesion molecule ICAM-1 in the infarct area did not differ between the groups, in line with recent findings 32 (data not shown). We however did observe a remarkable reduction of leucocyte recruitment into the circulation in C5aR 2/2 mice following IR, especially of CD4+ T cells ( Figure 6 ). Flow cytometric analysis also showed less activated CD4+ T cells by shedding of CD62L following IR (see Supplementary material online, Figure S5 ). This difference in activated CD4+ T cells, however, might be explained by the lower levels of circulating CD4+ T cells. These observations support the theory that T-cell activation and recruitment drive leucocyte chemotaxis into the injured myocardium, in line with previous findings. 34 Deposition of C3 in the infarct area was strongly reduced in C5aR
mice at 24 h after myocardial IR, indicating less local complement activation, despite that C5aR is downstream of C3. This finding suggests that leucocyte-mediated myocardial injury through C5aR drives further local complement activation. In the absence of C5aR, less leucocytes infiltrate the infarct area, inducing less damage and therefore limiting complement activation by DAMPs. This theory is in accordance with the previous finding that C5aR activation of T cells results in local complement activation. 37 The reduced infarct size and preservation of cardiac function appear to be mediated by attenuated leucocyte influx and less local complement activation. We also observed lower Caspase-3/7 levels in the infarcted tissue of C5aR 2/2 mice following IR ( Figure 5 ), pointing to less apoptosis as a contributing factor to infarct size reduction. Despite promising experimental evidence, the humanized anti-C5 monoclonal antibody Pexelizumab did not prove to be beneficial in patients undergoing urgent reperfusion therapy for AMI (PCI or CABG). A meta-analysis of randomized controlled trials only showed a reduction in death following CABG. 19 These results might partly be explained by the fact that Pexelizumab targets C5, which is earlier in the activation cascade and affects not only C5a but also the formation of C5b9 membrane attack complex. Besides, the reduction of C5a not only affects activation of C5aR but also of its alternative receptor C5L2. C5aR blockage is a more targeted approach affecting only C5aR expressing cells, making it more eligible for clinical application.
One of the limitations of our studies is that cardiac function was not assessed in chimaeric mice, so a potential role for parenchymal C5aR expression in the functional deterioration and adverse remodelling following myocardial IR cannot be excluded. Also, T-cell depletion studies to fully dissect the role of C5aR on myeloid cells vs. lymphoid cells have not been performed. It is important to address these issues in future studies.
In conclusion, this study demonstrates that C5aR-mediated reduction of infarct size after cardiac IR is solely determined by C5aR expression on BM-derived cells. This early infarct size reduction also results in improved cardiac function at longer term, which is important in view of possible clinical application. The reduction of infarct size in the absence of C5aR is associated with a reduced influx of several inflammatory cell types, including an ablation of T-cell infiltration, and reduced apoptosis. These findings point to a new role for T-cell C5aR activation in influencing myocardial damage after IR injury. However, additional research is needed to fully dissect the role of C5aR on myeloid cells vs. lymphoid cells. Selective inhibitors of the C5a-C5aR axis might be potential clinical candidates to improve cardiac function after myocardial IR injury.
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